CardoCHUVI registry was aim to study ischemic and bleeding complication after an acute coronary syndrome (ACS), both in-hospital and follow-up events.
CardioCHUVI is a retrospective study aim to analyze all consecutively patients admitted by acute coronary syndrome to University Hospital Alvaro Cunqueiro of Vigo, between January 2010 to January 2018 The objective of the project was to study cardiac and bleeding complications, such as reinfarction, heart failure, atrial fibrillation, stroke, and bleeding events, together with all-cause and cardiac mortality
Study Type
OBSERVATIONAL
Enrollment
8,000
Compare bleeding and ischemic events according to the type and duration of dual antiplatelet therapy
Department of Cardiology, Hospital Álvaro Cunqueiro
Vigo, Pontevedra, Spain
RECRUITINGAll cause mortality
Death for any cause
Time frame: Through study completion, an average of 3 years
Reinfarction
New spontaneous acute myocardial infarction
Time frame: Through study completion, an average of 3 years
Bleeding
Any bleeding according to BARC definition (from 1 to 5)
Time frame: Through study completion, an average of 3 years
Ischemic stroke
Ischemic stroke documented in CT
Time frame: Through study completion, an average of 3 years
Cancer
Any type of malignant cancer
Time frame: Through study completion, an average of 3 years
Heart Failure
Heart Failure admissions
Time frame: Through study completion, an average of 3 years
Atrial Fibrillation
Atrial fibrillation documented in ECG
Time frame: Through study completion, an average of 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.